NESTLE SA CDR (CAD Hedged)

NESTLE SA CDR (CAD Hedged)

NEST · NEO · Consumer Defensive / Packaged Foods

12.24CAD+0.26 (+2.17%)

Price History

Full chart

Market Stats

Previous Close11.98
Open12.24
Day Range12.24 – 12.24
52-Week Range9.49 – 12.04
Volume100
Market Cap26.96B
P/E (TTM)2.12
Forward P/E1.31
EPS4.95
Dividend Yield4.02%
Beta0.50
50-Day Avg11.01
200-Day Avg10.92

About

Nestlé S.A., together with its subsidiaries, manufactures and distributes food and beverage, and nutritional science products in the United States, Brazil, Mexico, Greater China, the Philippines, India, the United Kingdom, France, Germany, Switzerland, and internationally. The company offers cereals, chocolate and confectionery, coffee, culinary, chilled and frozen food, dairy, drinks, food service, ice cream, nutrition and health, petcare, water, plant-based portfolio, and recipe products. It sells its products under the Nesquik Cereal, Fitness, Cheerios, Lion Cereals, Cini Minis, KitKat Cereal, Chocapic, Koko Krunch, Shreddies, Shredded Wheat Original, Corn Flakes, Trix Cereal, Aero, Baci Perugina, KitKat, Milkybar, Smarties, Cailler, Quality Street, Garoto, Nestlé Toll House, Munch, Damak, Hsu Fu Chi, Sahne Nuss, Nestlé Sustainably Sourced Cocoa, Blue Bottle Coffee, Nescafé, Nescafé Dolce Gusto, Nespresso, Starbucks Coffee At Home, DiGiorno, Garden Gourmet, Maggi, Thomy, Stouffer's, Hot Pockets, Lean Cuisine, Life Cuisine, Buitoni, Nestlé carnation, Nestlé Coffee Mate, and Nestea brands. The company also offers its products under the Roastelier by Nescafé, Plant-based and so good!, Milo, Chef, Maggi Professional, La Lechera, Minor's, Antica Gelateria Del Corso, Drumstick, Extrême, Häagen-Dazs, Maxibon, Mövenpick, Nancare, Gerber, Cerelac, Nestum, Alfaré HMO, Athéra HMO, Alfamino HMO, Bear Brand, Nido, Orgain, Nestlé Vital, Garden of Life, Pure Encapsulations, Solgar, Compleat, Impact, Peptamen, Vitaflo, Resource, Cat Chow, Dentalife, Dog Chow, Fancy Feast, Felix, Friskies, Gourmet, Purina, Purina ONE, Purina Pro Plan, Purina Pro Plan Veterinary Diets, Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, Buxton, Erikli, Levissima, Vittel, Contrex, HENNIEZ, Hépar, La Vie, Naleczowianka, and Essentia brands. The company was founded in 1866 and is headquartered in Vevey, Switzerland. Aimmune Therapeutics, Inc. operates as a subsidiary of Nestlé S.A.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Philipp Navratil
  • Employees271.00K
  • HeadquartersAvenue Nestlé 55, Vevey, Switzerland, 1800, Canada
  • Websitehttps://www.nestle.com

Leadership

  • Mr. Philipp NavratilCEO & Member of the Executive Board · b. 1976
  • Ms. Anna Olive Magdelene ManzExecutive VP, CFO & Member of Executive Board · b. 1973
  • Mr. Stefan PalzerExecutive VP, CTO & Member of Executive Board · b. 1969
  • Ms. Leanne D. GealeExecutive VP, Group General Counsel & Member of the Executive Board · b. 1965
  • Mr. David RennieExecutive VP, Head of Strategic Business Units, Marketing & Sales and Member of Executive Board · b. 1966
  • Mr. Remy EjelExecutive VP, CEO of Zone Asia, Oceania & Africa and Member of Executive Board · b. 1969
  • Ms. Stephanie Pullings HartExecutive VP, COO & Member of Executive Board · b. 1972
  • Mr. Guillaume Le CunffExecutive VP, CEO of Zone Europe & Member of Executive Board · b. 1970
  • Ms. Anna LenzExecutive VP, Global Head of Human Resources & Member of Executive Board · b. 1980
  • Mr. Jeff HamiltonExecutive VP, CEO of Zone Americas (AMS) & Member of Executive Board

Financials

Income Statement

Currency: CHF2022-12-312023-12-312024-12-312025-12-31
Total Revenue94.78B93.35B91.72B89.89B
Growth (%)--1.51%-1.75%-2.00%
Cost of Revenue51.74B50.33B48.67B48.69B
Gross Profit43.03B43.02B43.05B41.19B
Gross Margin45.41%46.09%46.94%45.83%
Operating Expense27.37B27.35B27.44B27.21B
Operating Income15.67B15.67B15.61B13.98B
Operating Margin16.53%16.79%17.02%15.55%
EBITDA16.08B17.80B18.66B16.21B
EBITDA Margin16.96%19.07%20.35%18.03%
Net Income9.27B11.21B10.88B9.03B
Net Income Margin9.78%12.01%11.87%10.05%
R&D1.70B1.66B1.67B1.61B
R&D as % of Total Revenue1.79%1.77%1.82%1.79%
Interest Expense1.25B1.64B1.84B1.82B
Interest Expense % of Total Revenue1.32%1.76%2.01%2.03%

Balance Sheet

Currency: CHF2022-12-312023-12-312024-12-312025-12-31
Total Assets135.18B126.55B139.26B127.15B
Total Liabilities92.39B90.16B102.57B94.09B
Total Equity41.98B35.74B35.92B32.81B
Cash5.51B4.82B5.26B4.28B

Cash Flow

Currency: CHF2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow11.91B15.94B16.68B15.90B
Capital Expenditure5.36B6.20B5.96B4.91B
Free Cash Flow6.55B9.74B10.71B10.99B
Dividends Paid7.62B7.83B7.82B7.85B
FCF to OCF54.98%61.09%64.24%69.12%
Dividend Paid to FCF116.38%80.40%72.96%71.40%

Key Statistics & Ratios

Market Cap26.96B
Enterprise Value436.99B
Trailing P/E2.12
Forward P/E1.31
PEG Ratio0.15
Price / Sales0.30
Price / Book0.55
EPS4.95
Book Value19.47
Revenue (TTM)88.78B
Gross Profit (TTM)40.57B
EBITDA16.46B
Profit Margin8.38%
Operating Margin16.11%
Return on Equity26.24%
Return on Assets6.65%
Shares Outstanding2.57B
Shares Float2.57B
Beta0.50
Dividend Yield4.02%
Dividend Rate0.42
Payout Ratio8.49%

Dividends

20261×
0.42Apr 21, 2026
20251×
0.59Apr 22, 2025